Tadalafil Lilly

Country: Европска Унија

Језик: Енглески

Извор: EMA (European Medicines Agency)

Купи Сада

Активни састојак:

tadalafil

Доступно од:

Eli Lilly Nederland B.V.

АТЦ код:

G04BE08

INN (Међународно име):

tadalafil

Терапеутска група:

Urologicals

Терапеутска област:

Erectile Dysfunction

Терапеутске индикације:

Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective, sexual stimulation is required.Tadalafil Lilly is not indicated for use by women.Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.

Резиме производа:

Revision: 6

Статус ауторизације:

Authorised

Датум одобрења:

2017-03-22

Информативни летак

                                61
B. PACKAGE LEAFLET
62
PACKAGE LEAFLET: INFORMATION FOR THE USER
TADALAFIL LILLY 2.5 MG FILM-COATED TABLETS
tadalafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Tadalafil Lilly is and what it is used for
2.
What you need to know before you take Tadalafil Lilly
3.
How to take Tadalafil Lilly
4.
Possible side effects
5
How to store Tadalafil Lilly
6.
Contents of the pack and other information
1.
WHAT TADALAFIL LILLY IS AND WHAT IT IS USED FOR
Tadalafil Lilly is a treatment for adult men with erectile
dysfunction. This is when a man cannot get,
or keep a hard, erect penis suitable for sexual activity. Tadalafil
Lilly has been shown to significantly
improve the ability of obtaining a hard erect penis suitable for
sexual activity.
Tadalafil Lilly contains the active substance tadalafil which belongs
to a group of medicines called
phosphodiesterase type 5 inhibitors. Following sexual stimulation
Tadalafil Lilly works by helping the
blood vessels in your penis to relax, allowing the flow of blood into
your penis. The result of this is
improved erectile function. Tadalafil Lilly will not help you if you
do not have erectile dysfunction.
It is important to note that Tadalafil Lilly does not work if there is
no sexual stimulation. You and your
partner will need to engage in foreplay, just as you would if you were
not taking a medicine for
erectile dysfunction.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE TADALAFIL LILLY
DO NOT TAKE TADALAFIL LILLY IF YOU:
-
are allergic to tadalafil or any of the othe
                                
                                Прочитајте комплетан документ
                                
                            

Карактеристике производа

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Tadalafil Lilly 2.5 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Each tablet contains 2.5 mg tadalafil.
Excipient with known effect
Each coated tablet contains 87 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet).
Light orange-yellow and almond shaped tablets of 8.58 mm by 5.23 mm,
marked "C 2 ½" on one side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective, sexual stimulation is
required.
Tadalafil Lilly is not indicated for use by women.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adult men _
In general, the recommended dose is 10 mg taken prior to anticipated
sexual activity and with or
without food.
In those patients in whom tadalafil 10 mg does not produce an adequate
effect, 20 mg might be tried. It
may be taken at least 30 minutes prior to sexual activity.
The maximum dose frequency is once per day.
Tadalafil 10 and 20 mg is intended for use prior to anticipated sexual
activity and it is not
recommended for continuous daily use.
In patients who anticipate a frequent use of Tadalafil Lilly (i.e., at
least twice weekly) a once daily
regimen with the lowest doses of Tadalafil Lilly might be considered
suitable, based on patient choice
and the physician’s judgement.
In these patients the recommended dose is 5 mg taken once a day at
approximately the same time of
day. The dose may be decreased to 2.5 mg once a day based on
individual tolerability.
The appropriateness of continued use of the daily regimen should be
reassessed periodically.
3
_Special populations _
_Elderly men _
Dose adjustments are not required in elderly patients.
_Men with renal impairment _
Dose adjustments are not required in patients with mild to moderate
renal impairment. For patients
with severe renal impairment 10 mg is the maximum recommended dose.

                                
                                Прочитајте комплетан документ
                                
                            

Документи на другим језицима

Информативни летак Информативни летак Бугарски 21-09-2023
Информативни летак Информативни летак Шпански 21-09-2023
Информативни летак Информативни летак Чешки 21-09-2023
Информативни летак Информативни летак Дански 21-09-2023
Информативни летак Информативни летак Немачки 21-09-2023
Информативни летак Информативни летак Естонски 21-09-2023
Информативни летак Информативни летак Грчки 21-09-2023
Информативни летак Информативни летак Француски 21-09-2023
Карактеристике производа Карактеристике производа Француски 21-09-2023
Информативни летак Информативни летак Италијански 21-09-2023
Карактеристике производа Карактеристике производа Италијански 21-09-2023
Извештај о процени јавности Извештај о процени јавности Италијански 07-04-2017
Информативни летак Информативни летак Летонски 21-09-2023
Информативни летак Информативни летак Литвански 21-09-2023
Карактеристике производа Карактеристике производа Литвански 21-09-2023
Информативни летак Информативни летак Мађарски 21-09-2023
Информативни летак Информативни летак Мелтешки 21-09-2023
Информативни летак Информативни летак Холандски 21-09-2023
Карактеристике производа Карактеристике производа Холандски 21-09-2023
Информативни летак Информативни летак Пољски 21-09-2023
Информативни летак Информативни летак Португалски 21-09-2023
Карактеристике производа Карактеристике производа Португалски 21-09-2023
Извештај о процени јавности Извештај о процени јавности Португалски 07-04-2017
Информативни летак Информативни летак Румунски 21-09-2023
Информативни летак Информативни летак Словачки 21-09-2023
Информативни летак Информативни летак Словеначки 21-09-2023
Карактеристике производа Карактеристике производа Словеначки 21-09-2023
Извештај о процени јавности Извештај о процени јавности Словеначки 07-04-2017
Информативни летак Информативни летак Фински 21-09-2023
Информативни летак Информативни летак Шведски 21-09-2023
Информативни летак Информативни летак Норвешки 21-09-2023
Информативни летак Информативни летак Исландски 21-09-2023
Карактеристике производа Карактеристике производа Исландски 21-09-2023
Информативни летак Информативни летак Хрватски 21-09-2023

Обавештења о претрази у вези са овим производом

Погледајте историју докумената